1. Academic Validation
  2. Exploring host-pathogen interactions through genome wide protein microarray analysis

Exploring host-pathogen interactions through genome wide protein microarray analysis

  • Sci Rep. 2016 Jun 15;6:27996. doi: 10.1038/srep27996.
Luigi Scietti 1 Katia Sampieri 1 Irene Pinzuti 1 Erika Bartolini 1 Barbara Benucci 1 Alessia Liguori 1 Andreas F Haag 1 Paola Lo Surdo 1 Werner Pansegrau 1 Vincenzo Nardi-Dei 1 Laura Santini 1 Seguinde Arora 2 Xavier Leber 2 Simonetta Rindi 3 Silvana Savino 1 Paolo Costantino 1 Domenico Maione 1 Marcello Merola 1 4 Pietro Speziale 3 Matthew J Bottomley 1 Fabio Bagnoli 1 Vega Masignani 1 Mariagrazia Pizza 1 Meike Scharenberg 2 Jean-Marc Schlaeppi 2 Mikkel Nissum 1 Sabrina Liberatori 1
Affiliations

Affiliations

  • 1 GSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
  • 2 Novartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, Switzerland.
  • 3 Department of Molecular Medicine, Unit of Biochemistry, Viale Taramelli 3/b, 27100 Pavia, Italy.
  • 4 University of Naples "Federico II", Department of Biology, via Cinthia 4, 80126 Naples, Italy.
Abstract

During Bacterial pathogenesis extensive contacts between the human and the Bacterial extracellular proteomes take place. The identification of novel host-pathogen interactions by standard methods using a case-by-case approach is laborious and time consuming. To overcome this limitation, we took advantage of large libraries of human and Bacterial recombinant proteins. We applied a large-scale protein microarray-based screening on two important human pathogens using two different approaches: (I) 75 human extracellular proteins were tested on 159 spotted Staphylococcus aureus recombinant proteins and (II) Neisseria meningitidis adhesin (NadA), an important vaccine component against serogroup B meningococcus, was screened against ≈2300 spotted human recombinant proteins. The approach presented here allowed the identification of the interaction between the S. aureus immune evasion protein FLIPr (formyl-peptide receptor like-1 inhibitory protein) and the human complement component C1q, key players of the offense-defense fighting; and of the interaction between meningococcal NadA and human LOX-1 (low-density oxidized lipoprotein receptor), an endothelial receptor. The novel interactions between Bacterial and human extracellular proteins here presented might provide a better understanding of the molecular events underlying S. aureus and N. meningitidis pathogenesis.

Figures